CD8A and neoplasm: However, despite this lack of CD8 T cell expansion, we found that mice that were cured through CY treatment invariably resisted rechallenge with AB1-HA tumor cells (n = 20, data not shown), which indicates that the CD8 T cell response that was mobilized by CY treatment eventually generated tumor-specific memory.